Astec Lifesciences Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
202120222023
EBITDA1191650
EBIT941300
Earning Per Share334513
Expenses443522552
Net Profit659026
Net Profit Margin12134
Operating Profit Margin222414
Profit Before Tax8912135
Dividends Per Share220
Operation Revenue563687641

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
2023004,257NA4,993
2023001,222.70NA1,437.50
2010152.20179.8096802.17150.60
20230062.98NA83.60
202300502.21NA654.18
The EBITDA of Astec Lifesciences is 0 as of 3/5/2024
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20172017201720172023
Operating Activities1919191975
Investing Activities-18-18-18-18-113
Financing Activities-1-1-1-138
Others00000
Net Cash Flow1111-0

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
20237,751-1,490-6,22734
20231,501.40-496.20-483.10522.10
201045.95-22.99-46.71-23.75
2023-10.63-86.4079.68-17.35
2023389.38-327.19-72.55-10.36
The cash flow from Operating Activities of Astec Lifesciences is 75 as of 3/5/2024